#curevac

[ follow ]
NYC startup
fromMedCity News
1 month ago

BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute - MedCity News

BioNTech acquires CureVac to strengthen mRNA capabilities and mitigate legal risks amidst ongoing patent disputes.
[ Load more ]